NYSEARCA:VRAI

Virtus Real Asset Income ETF - VRAI Stock Forecast, Price & News

$24.93

-0.42 (-1.66%)

(As of 02/3/2023 09:05 PM ET)

Add

Today's Range: $24.89
▼
$25.17
50-Day Range: $23.39
▼
$25.35
52-Week Range: $21.43
▼
$30.25

Volume: 4,900 shs
Average Volume: 4,474 shs
Market Capitalization: $38.64 million

P/E Ratio: N/A
Dividend Yield: 4.18%
Price Target: N/A

Profile

Chart

Institutional Ownership

Receive VRAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus Real Asset Income ETF and its competitors with MarketBeat's FREE daily newsletter.

30 days | 90 days | 365 days | Advanced Chart

Receive VRAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus Real Asset Income ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Virtus

Fund NameVirtus Real Asset Income ETF

Tax ClassificationRegulated Investment Company

SymbolNYSEARCA:VRAI

Inception Date2/7/2019

Fund ManagerMatthew Brown, Seth Kadushin

WebN/A

PhoneN/A

Fund Focus

Asset ClassEquity

BenchmarkIndxx Real Asset Income Index

CategoryBroad Equity

FocusBroad Equity

Development LevelDeveloped Markets

RegionNorth America

Fund Statistics

Assets Under Management$38.78 million

Average Daily Volume$4,510.60

Discount/Premium-0.10%

ETF Expenses

Management Fee0.55%

Other Expenses0.00%

Total Expenses0.55%

Fee Waiver0.00%

Net Expenses0.55%

Administrator, Advisor and Custodian

AdministratorVirtus ETF Solutions, LLC

AdvisorVirtus ETF Advisers LLC

CustodianThe Bank of New York Mellon Corporation

DistributorETF Distributors LLC

Transfer AgentThe Bank of New York Mellon Corporation

Trustee

Lead Market MakerVirtu Financial

Geographic Exposure of VRAI

Currency Exposure of VRAI

Sector Exposure of VRAI

Industry Exposure of VRAI

VRAI Stock - Frequently Asked Questions

How have VRAI shares performed in 2023?: Virtus Real Asset Income ETF's stock was trading at $23.6219 at the beginning of the year. Since then, VRAI shares have increased by 5.5% and is now trading at $24.9276.
View the best growth stocks for 2023 here.
Is Virtus Real Asset Income ETF a good dividend stock?: Virtus Real Asset Income ETF (NYSEARCA:VRAI) pays an annual dividend of $1.06 per share and currently has a dividend yield of 4.18%. VRAI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for VRAI.

What is Virtus Real Asset Income ETF's stock symbol?: Virtus Real Asset Income ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "VRAI."
How do I buy shares of Virtus Real Asset Income ETF?: Shares of VRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Virtus Real Asset Income ETF's stock price today?: One share of VRAI stock can currently be purchased for approximately $24.93.
How much money does Virtus Real Asset Income ETF make?: Virtus Real Asset Income ETF (NYSEARCA:VRAI) has a market capitalization of $38.64 million.

This page (NYSEARCA:VRAI) was last updated on 2/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial